Table 4. Clinical Outcomes and Incidence of Adverse Events in the Study Patientsa.
| SP | PS | SS | PP | P Value | |
|---|---|---|---|---|---|
| Number | 22 | 22 | 22 | 23 | NA |
| Death | 0 | 0 | 1 (4.54) | 1 (4.3) | 0.865 |
| MI | 0 | 0 | 0 | 1 (4.3) | 1.00 |
| IABP | 0 | 0 | 0 | 0 | NA |
| Dialysis | 0 | 0 | 0 | 0 | NA |
| CVA | 1 (4.54) | 0 | 0 | 1 (4.34) | 1.00 |
| Severe infection | |||||
| Pneumonia (requiring ventilation) | 0 | 0 | 0 | 0 | NA |
| DSWI | 0 | 0 | 0 | 1 (4.34) | 1.00 |
| Minor infection | |||||
| Pneumonia (not requiring ventilation) | 2 (9.09) | 2 (9.09) | 1 (4.54) | 3 (13.04) | 0.956 |
| Superficial wound infection | 2 (9.09) | 1 (4.54) | 0 | 6 (26.08) | 0.025 |
| UTI | 2 (9.09) | 0 | 0 | 1 (4.34) | 0.455 |
| Blood transfusion | |||||
| RBC, mL/patient | |||||
| Number (percent) | 20 (90.90) | 19 (86.36) | 18 (81.81) | 21 (91.30) | 0.886 |
| Unit/Patient | 3.55 ± 2.36 | 2.72 ± 1.79 | 2.74 ± 1.72 | 3.84 ± 2.15 | 0.176 |
| FFP, mL/patient | |||||
| Number (percent) | 3 (13.63) | 4 (18.18) | 2 (9.09) | 6 (26.08) | 0.502 |
| Unit/Patient | 3.15 ± 0.78 | 3.85 ± 1.30 | 3.00 ± 1.41 | 4.14 ± 2.11 | 0.786 |
| Platelets (mL/patient) | |||||
| number (percent) | 1 (4.54) | 1 (4.54) | 2 (9.09) | 1 (4.34) | 0.935 |
| unit/patient | 2.0 | 4.0 | 4.00 ± 2.8 | 4.0 | 0.734 |
| Intubation time, h | 10 (8 - 14) | 9.9 (8.2 - 12.0) | 9.7 (7.1 - 11.1) | 10.0 (6.5 - 13.5) | 0.886 |
| ICU stay, h | 43.0 (40.5 - 48.0) | 43.0 (39.7 - 51.0) | 42 (41 - 43) | 43 (39 - 44) | 0.598 |
| Hospital stay, d | 3 (3 - 4) | 4 (3 - 4) | 3 (3 - 4) | 4 (3 - 4) | 0.311 |
Abbreviations:CVA, cerebrovascular accident; DSWI, deep sternal wound infection; FFP: fresh frozen plasma; IABP, intra-aortic balloon pump; MI, myocardial infarction; RBC, red blood cell; UTI, urinary tract infection.
aData are expressed as No. (%), median (interquartile range), or Mean ± SD.